Anders Sundin

Prof

Uppsala Universitet Medicinska fakulteten

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Medical Imaging Medical Imaging professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Anders Sundin is a faculty member at Uppsala Universitet Medicinska fakulteten in Sweden. His research primarily focuses on neuroendocrine tumors, including their treatment, imaging, and genetic factors influencing therapy response. Recent publications include studies on the predictive value of hypoalbuminemia in patient survival, the prevalence of metastases in neuroendocrine tumors, and advancements in imaging techniques for accurate diagnosis.

Articles (9)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Collaborators (7)

Jan Calissendorff

Karolinska University Hospital

SWEDEN

View details

David Mark Pritchard

Professor of Gastroenterology

University of Liverpool

UNITED KINGDOM

View details

Henrik Falhammar

Karolinska Institutet

SWEDEN

View details

john ramage

King’s College London

UNITED KINGDOM

View details

Carl Christofer Juhlin

Karolinska Institutet

SWEDEN

View details

Liang Zhang

Uppsala University

SWEDEN

View details

Katarina Edfeldt

Senior lecturer

Uppsala University

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anders Sundin

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Prevalence of metastases outside the liver and abdominal lymph nodes on 68Ga‐DOTATOC‐PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours

Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors

Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients

Adrenal cysts: an emerging condition

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1–G3

Improved health‐related quality of life during peptide receptor radionuclide therapy in patients with neuroendocrine tumours

Primary hyperparathyroidism, a machine learning approach to identify multiglandular disease in patients with a single adenoma found at preoperative Sestamibi-SPECT/CT

Commentary on Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant masses

68Ga‐DOTATOC‐PET/MRI and 11C‐5‐HTP‐PET/MRI are superior to 68Ga‐DOTATOC‐PET/CT for neuroendocrine tumour imaging

Collaborators (7)

Jan Calissendorff

David Mark Pritchard

Henrik Falhammar

john ramage

Carl Christofer Juhlin

Liang Zhang

Katarina Edfeldt

Make your next move.